{"nct_id":"NCT02492737","title":"Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 Mutation","status":"COMPLETED","status_verified_date":"2019-03","start_date":"2015-08-07","start_date_type":"ACTUAL","primary_completion_date":"2018-03-21","primary_completion_date_type":"ACTUAL","completion_date":"2018-03-21","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["AGIO"]}